Mental Health Pharmacy Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Compounded "Monster Spray" for Nighttime Terrors: A Case Report
Riepl Mike
|
Nov/Dec 2023
Pg. 446-448
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID
Riepl Mike, Kaiser Joe
|
Jul/Aug 2023
Pg. 284-293
|
Clobazam 5-mg/mL Suspension
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 317-318
|
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study
Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
|
Mar/Apr 2023
Pg. 108-112
|
Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 51
|
Methylcobalamin 2-mg/mL Nasal Spray
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 431
|
Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
|
Jul/Aug 2022
Pg. 342-351
|
Azstarys in Ora-Blend Single Dose
Allen Loyd V Jr
|
May/Jun 2022
Pg. 233
|
Clobazam 1 mg/mL in Oral-Mix Suspension
Allen Loyd V Jr
|
May/Jun 2022
Pg. 237
|
Nitrazepam 1 mg/mL Oral Solution
Allen Loyd V Jr
|
May/Jun 2022
Pg. 239
|
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 140
|
Lorazepam 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 143
|
Quetiapine Fumarate 10 mg/mL in Ora-Blend
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 506
|
Clonidine 0.01-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 414
|
Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 417
|
Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 418
|
Atomoxetine 4-mg/mL Oral Solution/Suspension
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 321
|
Stability of Dexmedetomidine in Polyvinyl Chloride Bags Containing 0.9% Sodium Chloride Intended for Subcutaneous Infusions
Wolfe Amanda, Zhang Jeremy, Lapenskie Julie, Downar James, Kanji Salmaan
|
Jul/Aug 2021
Pg. 330-335
|
Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension
Allen Loyd V Jr
|
May/Jun 2021
Pg. 233
|
The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report
McKettrick Greg, Yoch Doug
|
Mar/Apr 2021
Pg. 94-98
|
Doxepin Hydrochloride 5% in Cetaphil Cream
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 314
|
Hydroxyzine (Pamoate) 25-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 317
|
Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 319
|
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C
|
Jul/Aug 2020
Pg. 327-336
|
Venlafaxine 15 mg/mL in Ora-Plus:Ora-Sweet (1:1) Suspension
Allen Loyd V Jr
|
May/Jun 2020
Pg. 233
|
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 60
|
Venlafaxine 15 mg/mL in Syrup
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 63
|
Amitriptyline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 407
|
Aripiprazole 1 mg/mL in Oral-Plus:Ora-Sweet (1:1) Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 314
|
Aripiprazole 1 mg/mL in Methylcellulose 1% Syrup Oral Suspension
Allen Loyd V Jr
|
May/Jun 2019
Pg. 230
|
Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia
Zur Eyal
|
Mar/Apr 2019
Pg. 113-119
|
Perphenazine 0.5 mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 151
|
Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream
Shakshuki Ayah, Agu Remigius U
|
Jan/Feb 2019
Pg. 82-87
|
Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 409
|
Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 321
|
The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia
Cote Brianna, Ross Bethany, Fortner Jeff, Rao Deepa
|
May/Jun 2018
Pg. 252-256
|
Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients
McElhiney Linda F
|
Jan/Feb 2018
Pg. 30-39
|
Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 490
|
Haloperidol 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 493
|
Sertraline Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 318
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Deleruyelle Laura J
|
Jan/Feb 2017
Pg. 6-16
|
Clobazam 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 406
|
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
|
May/Jun 2016
Pg. 257-261
|
Aripiprazole 10-mg Oral Dissolving Tablets
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 49
|
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 507
|
Memantine Hydrochloride Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 511
|
Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches
Allen Loyd V Jr
|
May/Jun 2015
Pg. 244
|
Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 496
|
Methylphenidate Hydrochloride 10-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 501
|
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice
McNulty John P, Muller George
|
May/Jun 2014
Pg. 190-200
|
Thiothixene 1-mg, 2-mg, 5-mg, or 10-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 241
|
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita
|
May/Jun 2014
Pg. 253-255
|
The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study
Ruiz Andres D, Daniels Kelly R
|
Jan/Feb 2014
Pg. 70-77
|
Hydroxyzine Hydrochloride 25-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 418
|
Adrenal Fatigue
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 39-44
|
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
|
Jan/Feb 2013
Pg. 74-85
View Sample |
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report
McNulty Jack P, Hahn Kristian
|
Sep/Oct 2012
Pg. 364-368
|
Haloperidol 50-mg/mL in Oil Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 422
|
A Concise Discussion of Headache Types, Part 3: Migraine
Williams LaVonn A, Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 270-274
|
Etomidate 2-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 335
|
Prochlorperazine 5-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 246
|
Midazolam 5-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 162
|
Promethazine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 163
|
Caffeine Citrate 20-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 156
|
Lorazepam 4-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 161
|
Vitamins: Therapy or Hype
Wynn Tom, Hoffrogge Zach
|
Jan/Feb 2012
Pg. 17-21
|
Calculations
Stockton Shelly J
|
Jan/Feb 2012
Pg. 69
|
Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 308-315
|
Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient
Bramwell Bethany
|
Jul/Aug 2011
Pg. 316-319
|
Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 342
|
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration
Wynn Tom, Goetsch Daniel
|
May/Jun 2011
Pg. 200-203
|
Melatonin 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2011
Pg. 246
|
Stability of Venlafaxine Immediate-Release Suspensions
Donnelly Ronald F, Wong Keith, Goddard Rob, Johanson Christel
|
Jan/Feb 2011
Pg. 81-84
|
Glutathione 25% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 518
|
The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women
Bramwell Bethany L
|
Nov/Dec 2010
Pg. 465-471
|
Bromazepam 2.5-mg/mL Drops
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 515
|
Buspirone 2.5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 424
|
Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 427
|
Amitriptyline Hydrochloride Suppositories
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 334
|
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser
Christiansen Joel, White Lyndell
|
Jul/Aug 2010
Pg. 310-314
|
Clozapine 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 243
|
Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword?
Williams LaVonn A
|
Mar/Apr 2010
Pg. 105-107
|
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
|
Mar/Apr 2010
Pg. 171-173
|
Sleepless in America: Compounding with Melatonin
Wynn Tom, Rawlings Kate
|
Jan/Feb 2010
Pg. 10-13
|
Low Testosterone in Older Men: A Discussion and Review of Literature on Health Consequences of Hypogonadism in the Aging Male
Biundo Bruce
|
Nov/Dec 2009
Pg. 494-496
|
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms
Gupta Vishnu D
|
Sep/Oct 2009
Pg. 445-446
|
Compounding Naltrexone for the Treatment of Autism
Wynn Tom, Brunetti Sarah
|
Jul/Aug 2009
Pg. 296-299
|
Thiothixene Hydrochloride 2-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 159
|
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms
Gupta Vishnu D
|
Jul/Aug 2008
Pg. 372-374
|
Methylphenidate 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 249
|
Psychotropic Medications in the Treatment of Feline Urine Spraying
Simpson Barbara Sherman, Vail Jane
|
Jan/Feb 2007
Pg. 44-48
|
Fluoxetine Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 73
|
Disulfiram 25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 455
|
Naltrexone 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 459
|
Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety
Fields Shannon W
|
Nov/Dec 2006
Pg. 418
|
Calculations: Compounding for Large and Small Animals
Stockton Shelly J
|
Nov/Dec 2006
Pg. 449
|
Midazolam Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 387
|
Adderall 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 299
|
Lamotrigine 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 223
|
Trazodone Hydrochloride 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 146
|
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Moon Richard B
|
Mar/Apr 2006
Pg. 95-98
|
The Dying Process
Fonseca Simonne C
|
Mar/Apr 2006
Pg. 103-106
|
Unlocking Autism: Is Compounding the Key?
Vail Jane
|
Nov/Dec 2005
Pg. 413-420
|
Alprazolam 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 472
|
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms
Gupta Vishnu D
|
Nov/Dec 2005
Pg. 484-486
|
PostScription: Compounding Pharmacies and the Successful Treatment of Autism
Neurander James A
|
Nov/Dec 2005
Pg. 487-488
|
Compounding for Behavior Problems in Animals
Vail Jane, Davidson Gigi S
|
May/Jun 2005
Pg. 185-192
|
Amitriptyline Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2005
Pg. 62
|
Naltrexone Hydrochloride 1.4-mg/mL Injection, Preservative Free
Allen Loyd V Jr
|
Jan/Feb 2005
Pg. 67
|
Enhanced Release of Diazepam from Hollow-Type Suppositories
Kaewnopparat N, Kaewnopparat S, Rojanarat W, Ingkatawornwong S
|
Jul/Aug 2004
Pg. 310-312
|
Selegiline HCl 10-mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 59
|
Ergoloid Mesylate 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 470
|
Perphenazine 2.5-mg/5-mL Syrup
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 473
|
Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women
Mason Dave
|
Jul/Aug 2002
Pg. 255-256
|
Bioidentical Hormone Replacement Therapy, Part 2, A Review of
Wepfer Scott T
|
Jan/Feb 2002
Pg. 50-54
|
Natural Progesterone in Natural Hormone Replacement Therapy, The Role of
Girouard Lorinda G, Holm Richard C
|
May/Jun 2001
Pg. 218-220
|
The Use of Psychoactive Agents in Veterinary Medicine
Simpson Barbara S
|
Mar/Apr 2001
Pg. 86-88
|
Piracetam 100-mg, Ergoloid Mesylates 6-mg, and Selegiline 2.5-mg/0.2-mL Gel ("Brain Gel")
Roentsch George
|
Mar/Apr 2001
Pg. 160
|
Autism in Children
Cave Stephanie
|
Jan/Feb 2001
Pg. 18-19
|
Methylphenidate in the Treatment of Attention Deficit Disorders
Tenreiro Kim
|
Jan/Feb 2001
Pg. 21-22
|
Lorazepam 1-mg Chewable Gummy Gels
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 45
|
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Glasnapp Andrew, Schaefer Erin
|
Jul/Aug 2000
Pg. 276-279
|
Pharmacological Treatment Options for Snoring
Osburn Jennifer, Allen Michelle, Kuntz Rachael
|
May/Jun 2000
Pg. 179
|
Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium
Jones Marty
|
Jan/Feb 2000
Pg. 6-15
|
The Psychology of Pain
Jones Marty
|
Jan/Feb 2000
Pg. 12-13
|
Sertraline 7.5-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 1998
Pg. 443
|
Essential Truths About HRT
Everett Lisa, Everett Eric
|
Jan/Feb 1998
Pg. 10-11
|
Interview on HRT: Christiane Northrup, MD, FACOG
Allen Loyd V Jr, Northrup Christiane
|
Jan/Feb 1998
Pg. 12-17
|
HRT and the Continuing Education of Health Care Professionals
Boomsma Diane
|
Jan/Feb 1998
Pg. 18-19
|
Estrogen and Breast Cancer: Is There a Link?
Gever Marcy Portnoff
|
Jan/Feb 1998
Pg. 21-23
|
Estrogen in the Treatment and Prevention of Alzheimer's Disease
Paganini-Hill Annlia, Henderson Victor W
|
Jan/Feb 1998
Pg. 24-29
|
Reviews: Books on HRT
Ford Gina
|
Jan/Feb 1998
Pg. 30-34
|
The Formulation and Use of Placebo Dosage Forms in Pharmacy
Al-Achi Antoine, Greenwood Robert
|
Jan/Feb 1998
Pg. 35-37
|
Stability of Clonazepam Suspension in HSC Vehicle
Roy Julie J, Besner Jean-Guy
|
Nov/Dec 1997
Pg. 440-441
|
Attention Deficit Hyperactivity Disorder
Allen Loyd V Jr
|
Mar/Apr 1997
Pg. 87-89
|
Aromatherapy and the Hospice Patient
Allen Loyd V Jr
|
Jan/Feb 1997
Pg. 18-19
|
Aromatherapy Mood Elevation No. 1
Allen Loyd V Jr
|
Jan/Feb 1997
Pg. 20
|
Aromatherapy Mood Elevation No. 2
Allen Loyd V Jr
|
Jan/Feb 1997
Pg. 21
|
Return to Top |